The immune-endothelial axis in neurovascular pathophysiology: a framework for targeted interventions - Top-Institutions - MDSpire

The immune-endothelial axis in neurovascular pathophysiology: a framework for targeted interventions

  • By

  • Chang Li

  • Baofeng Xu

  • Rui Liu

  • May 18, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Neurology
    • Neurosurgery

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Neurology
    • Neurosurgery

  • #3

    National Institute of Neurological Disorders and Stroke
    National Institute of Neurological Disorders and Stroke

    Bethesda, Maryland

    Key Differentiators

    • Neurology

  • #4

    EU consortium ENTRAIN
    EU consortium ENTRAIN

    Various, Europe

    Key Differentiators

    • Neuroscience

  • #5

    Schepens Eye Research Institute of Harvard Medical School
    Schepens Eye Research Institute of Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Ophthalmology
    • Neuroscience

Original Source(s)

The immune-endothelial axis in neurovascular pathophysiology: a framework for targeted interventions

  • by Chang Li, Baofeng Xu, Rui Liu

  • May 18, 2026

Related Content

Prognostic significance of coagulation factor activity in acute stroke: a retrospective cohort study

2026 Brain and Spine Symposium Highlights Advances Across the Neurosciences

Over two days, specialists across neurology, neurosurgery and related subspecialties came together to discuss advances in stroke care, epilepsy, movement disorders, neurodegenerative disease, neuro-oncology, brain and spine surgery, interventional pain management and emerging technologies.

  • by

  • May 21, 2026

  • 1 min
Association between uric acid to lymphocyte ratio and poor functional outcomes in acute ischemic stroke patients